ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 259 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $11,151,000 | +60.6% | 119,983 | +2.9% | 0.22% | +54.9% |
Q3 2021 | $6,944,000 | -27.0% | 116,608 | -16.4% | 0.14% | -15.8% |
Q2 2021 | $9,516,000 | -6.6% | 139,530 | -5.0% | 0.17% | -9.5% |
Q1 2021 | $10,193,000 | -20.7% | 146,901 | -12.2% | 0.19% | -22.5% |
Q4 2020 | $12,858,000 | – | 167,354 | – | 0.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Avoro Capital Advisors LLC | 4,190,000 | $321,918,000 | 5.54% |
Prosight Management, LP | 145,700 | $11,194,000 | 5.17% |
Integral Health Asset Management, LLC | 200,000 | $15,366,000 | 4.57% |
Copernicus Capital Management, LLC | 3,740 | $287,000 | 4.47% |
GREAT POINT PARTNERS LLC | 345,120 | $26,516,000 | 4.31% |
Asymmetry Capital Management, L.P. | 101,245 | $7,779,000 | 3.55% |
First Light Asset Management, LLC | 321,967 | $24,737,000 | 1.83% |
DAFNA Capital Management LLC | 76,815 | $5,902,000 | 1.76% |
SECTORAL ASSET MANAGEMENT INC | 320,059 | $24,590,000 | 1.73% |
Nicholas Investment Partners, LP | 276,633 | $21,254,000 | 1.64% |